| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Loss before income taxes | -18.266 | 2.131 | -22.14 | -29.624 |
| Income tax expense | 1.336 | -0.186 | 0.496 | 0.226 |
| Net loss | -19.602 | 2.317 | -22.636 | -29.85 |
| Unrealized income on available for sale securities, net of tax of nil (note 5) | 0.29 | 0.066 | 0.546 | 1.905 |
| Total other comprehensive income | 0.29 | 0.066 | 0.546 | 1.905 |
| Comprehensive loss | -19.312 | 2.383 | -22.09 | -27.945 |
| Basic (in dollars per share) | -0.26 | 0.03 | -0.3 | -0.39 |
| Basic (in shares) | 75,767,778 | 75,337,168 | 75,171,020 | 76,128,531 |
| Diluted (in dollars per share) | -0.26 | 0.03 | -0.3 | -0.39 |
| Diluted (in shares) | 75,775,214 | 77,378,449 | 75,226,387 | 76,157,101 |
Zymeworks Inc. (ZYME)
Zymeworks Inc. (ZYME)